Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT-OCT in STEMI patients
NCT06339021Phase 1Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clopidogrel in ST elevation myocardial infarction (STEMI), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Neointimal thickness after DES implantation at 12 months. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06339021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339021.